Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients
Condition:   Candida InfectionsIntervention:   Sponsors:   Outcome Rea;   Assistance Publique - Hôpitaux de ParisNot yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2015 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2013 Category: Research Source Type: clinical trials

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Conditions:   Leukemia,;   Allogeneic Hematopoietic Stem Cell TransplantationIntervention:   Drug: Caspofugin + voriconazole or amphotericin BSponsor:   Shanghai Jiao Tong University School of MedicineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2011 Category: Research Source Type: clinical trials